Literature DB >> 17169765

Patient with resected anaplastic astrocytoma and an image suggestive of relapse.

S Maciá Escalante1, A Rodríguez Lescure, J M Segura Ibáñez, J Sáez Castán, C Guillén Ponce, A Carrato Mena.   

Abstract

The main treatment of asctrocytomas is surgery, which serves a double purpose: diagnosis and treatment. Surgery can be complemented with radiotherapy. With respect to chemotherapy, there continues to be a controversy as to whether it has the capacity to overcome the blood-brain barrier. An interesting option has been the implantation of biodegradable polymers of carmustine that are placed in the cavity left by the surgical procedure. With respect to the cerebral edema that can be associated with the carmustine implants, there can appear images in follow-up that are suggestive of relapse.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17169765     DOI: 10.1007/s12094-006-0155-0

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  4 in total

1.  Treatment of brain tumors.

Authors:  Robert D Aiken
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

Review 2.  Novel therapeutics in adult malignant brain gliomas.

Authors:  Michele Reni; Elena Mazza; Alicia Tosoni; Alba A Brandes
Journal:  Expert Opin Investig Drugs       Date:  2005-06       Impact factor: 6.206

3.  Cerebral edema associated with Gliadel wafers: two case studies.

Authors:  Emil L Weber; Eric A Goebel
Journal:  Neuro Oncol       Date:  2005-01       Impact factor: 12.300

Review 4.  Recent advances in brain tumor therapy: local intracerebral drug delivery by polymers.

Authors:  Christopher Guerin; Alessandro Olivi; Jon D Weingart; H Christopher Lawson; Henry Brem
Journal:  Invest New Drugs       Date:  2004-01       Impact factor: 3.850

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.